Literature DB >> 8137292

Activation of the leukocyte plastin gene occurs in most human cancer cells.

T Park1, Z P Chen, J Leavitt.   

Abstract

Examination of human neoplastic cell lines using reverse transcription-polymerase chain reaction (RT-PCR), Northern blotting, and protein profiling revealed that > 90% of transformed human cell lines surveyed exhibited widely varying degrees of activation of the leukocyte (L)-plastin gene. By contrast, diploid cell types exhibited no evidence of event transient activation of this gene. The low level activation of the L-plastin gene, detectable only by RT-PCR, was confirmed by using the recombinant human L-plastin promoter to select "L-plastin positive" clonal subpopulations from these RT-PCR-positive cell lines. A stable cell line selected by this method exhibited low level constitutive synthesis of L-plastin mRNA and polypeptide. This cell line also exhibited the coinduction of at least three highly abundant new cytoplasmic proteins (M(r) 42,000, 37,000, and 34,000) and reduction in growth rate and saturation density. Most clonal cell lines derived by this selection procedure that activated the L-plastin gene exhibited a crisis stage that led to death of the clonal strain, a phenomenon that could be reproduced by induction of synthesis of recombinant L-plastin from its complementary DNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137292

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks.

Authors:  A J Butte; P Tamayo; D Slonim; T R Golub; I S Kohane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.

Authors:  Yan Ning; Armin Gerger; Wu Zhang; Diana L Hanna; Dongyun Yang; Thomas Winder; Takeru Wakatsuki; Melissa J Labonte; Sebastian Stintzing; Nico Volz; Yu Sunakawa; Stefan Stremitzer; Rita El-Khoueiry; Heinz-Josef Lenz
Journal:  Mol Cancer Ther       Date:  2013-10-29       Impact factor: 6.261

3.  Nanobody-induced perturbation of LFA-1/L-plastin phosphorylation impairs MTOC docking, immune synapse formation and T cell activation.

Authors:  Sarah De Clercq; Olivier Zwaenepoel; Evelien Martens; Joël Vandekerckhove; Aude Guillabert; Jan Gettemans
Journal:  Cell Mol Life Sci       Date:  2012-09-23       Impact factor: 9.261

4.  Steroid hormone induction and expression patterns of L-plastin in normal and carcinomatous prostate tissues.

Authors:  J Zheng; N Rudra-Ganguly; G J Miller; K A Moffatt; R J Cote; P Roy-Burman
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

5.  Suppression of prostate carcinoma cell invasion by expression of antisense L-plastin gene.

Authors:  J Zheng; N Rudra-Ganguly; W C Powell; P Roy-Burman
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

6.  An invasion-associated Salmonella protein modulates the actin-bundling activity of plastin.

Authors:  D Zhou; M S Mooseker; J E Galán
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

7.  Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray.

Authors:  Loleta D Harris; Jorge De La Cerda; Tomasz Tuziak; Daniel Rosen; Lianchun Xiao; Yu Shen; Anita L Sabichi; Bogdan Czerniak; H Barton Grossman
Journal:  Mol Carcinog       Date:  2008-09       Impact factor: 4.784

8.  Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over.

Authors:  Ziad Al Tanoury; Elisabeth Schaffner-Reckinger; Aliaksandr Halavatyi; Céline Hoffmann; Michèle Moes; Ermin Hadzic; Marie Catillon; Mikalai Yatskou; Evelyne Friederich
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

9.  Fascin Rigidity and L-plastin Flexibility Cooperate in Cancer Cell Invadopodia and Filopodia.

Authors:  Isabel Van Audenhove; Majken Denert; Ciska Boucherie; Leen Pieters; Maria Cornelissen; Jan Gettemans
Journal:  J Biol Chem       Date:  2016-03-04       Impact factor: 5.157

Review 10.  Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists.

Authors:  C A Lunn; E-P Reich; J S Fine; B Lavey; J A Kozlowski; R W Hipkin; D J Lundell; L Bober
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.